5012 V (Phenobarbital 32.4 mg)
Pill imprint 5012 V has been identified as Phenobarbital 32.4 mg.
Phenobarbital is used in the treatment of seizures; sedation; insomnia; hyperbilirubinemia and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Phenobarbital 32.4 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Images for 5012 V (Phenobarbital 32.4 mg)
- 32.4 mg
- Prescription only
- Drug Class:
- Barbiturate anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Qualitest Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|63739-0201||McKesson Packaging Services|
|67544-0057||Prepak Systems Inc (repackager)|
|55289-0535||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.